Greater Cannabis Company (GCAN) Cash & Equivalents (2017 - 2026)

Greater Cannabis Company's Cash & Equivalents history runs 10 years deep, the most recent figure standing at $1439.0 for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 96.89% year-over-year to $1439.0; the TTM figure through Mar 2026 stood at $1439.0 (down 96.89% YoY), while the FY2025 annual figure was $815.0, down 98.58% from the prior year.
• Cash & Equivalents was $1439.0 for Q1 2026 at Greater Cannabis Company, up from $815.0 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $289094.0 in Q3 2022 to a low of $815.0 in Q4 2025.
• Historically, Cash & Equivalents has averaged $113720.4 across 5 years, with a median of $71299.0 in 2024.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents slipped 28.47% in 2022, then tumbled 98.58% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $270030.0 in 2022, then plunged by 38.21% to $166859.0 in 2023, then tumbled by 65.62% to $57368.0 in 2024, then sank by 98.58% to $815.0 in 2025, then surged by 76.56% to $1439.0 in 2026.
• The last three Cash & Equivalents figures came in at $1439.0 (Q1 2026), $815.0 (Q4 2025), and $21355.0 (Q3 2025), per Business Quant data.